Related Experiment Video
Updated: Sep 16, 2025

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
Published on: May 22, 2020
A Case of Cryoglobulinemic Nephritis That Responded to Rituximab Monotherapy
Kumiko Fujieda1, Akihito Tanaka1, Kayaho Maeda1
1Department of Nephrology, Nagoya University Hospital, Nagoya, JPN.
Abstract:
The patient was a 65-year-old woman with ascites effusion and portal hypertension of unknown cause for the past three years, who was followed up with diuretics. Subsequently, the patient developed abdominal distention and worsening leg edema, and the laboratory test results revealed positive antinuclear antibodies, mild renal impairment, and abnormal urinalysis. After renal biopsy and laboratory tests, the patient was diagnosed with cryoglobulinemic nephritis. She was treated with rituximab monotherapy, which resulted in decreased serum creatinine and urinary protein levels and suppression of complement lowering. Thus, rituximab treatment may be effective for cryoglobulinemic nephritis.
More Related Videos
07:25In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
06:37Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management